26 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
pandemic and macroeconomic factors that could impact our business, such as supply chain and inflationary pressures and the effects of the Russian … , interruptions or other adverse
effects to clinical trials and patient enrollment; delays in regulatory review; manufacturing and supply chain interruptions
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
, quality systems, manufacturing, supply chain, product development, formulation, and IT. From 2009 to 2011, Mr. Le was the Chief Operating Officer
DEFM14A
oa26q2 cfke
24 Jun 22
Proxy related to merger
4:44pm
424B3
dxirnpzyf9h3 b5s2iw0
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
j0w9 7m9o2ruxzmam72
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
0aj95iqwxs6n
13 May 22
Registration of securities issued in business combination transactions
5:10pm
424B5
5xm1yrr
23 Jun 21
Prospectus supplement for primary offering
12:26pm
424B5
nuwmeygxl y9dv5ycobk
22 Jun 21
Prospectus supplement for primary offering
5:23pm
424B3
io9el jk8n6d
28 Apr 21
Prospectus supplement
9:49pm